DrugPatentWatch Database Preview
Profile for United States of America Patent: 8546379
US Patent Family Members and Approved Drugs for United States of America Patent: 8546379
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Apr 10, 2023 | Eisai Inc | BELVIQ XR | lorcaserin hydrochloride |
➤ Sign Up | Apr 10, 2023 | Eisai Inc | BELVIQ | lorcaserin hydrochloride |
➤ Sign Up | Apr 10, 2023 | Eisai Inc | BELVIQ XR | lorcaserin hydrochloride |
➤ Sign Up | Apr 10, 2023 | Eisai Inc | BELVIQ | lorcaserin hydrochloride |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |